Antimicrobial resistance (AMR) is a growing public health concern, causing significant mortality and morbidity worldwide.This report discusses global AMR concerns and the value of diagnostics and susceptibility tests for guiding informed treatment decisions in healthcare settings. The project – involving multidisciplinary collaborators – investigates the cost-benefit advantages of implementing antimicrobial stewardship programs (ASPs) with rapid diagnostics at the point of care.

This work was funded by a grant from bioMérieux.

Francesca Chiara, PhD, MPH, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research and Policy 

Natalie Vestin, MPH, Research Associate, Center for Infectious Disease Research and Policy 

CIDRAP
February 15, 2023